•• Yang X, Quam MBM, Zhang T, Sang S. Global burden for dengue and the evolving pattern in the past 30 years. J Travel Med. 2021;28(8). Best overview on the epidemiology of dengue in the past and present with projections for the future.

Javelle E, Gautret P, Simon F. Chikungunya, the emerging migratory rheumatism. Lancet Infect Dis. 2015;15(5):509–10.

Article  PubMed  Google Scholar 

Lin Y, Fang K, Zheng Y, Wang HL, Wu J. Global burden and trends of neglected tropical diseases from 1990 to 2019. J Travel Med. 2022;29(3).

Fischer M, Staples JE, Arboviral Diseases Branch NCfE, Zoonotic Infectious Diseases CDC. Notes from the field: chikungunya virus spreads in the Americas - Caribbean and South America, 2013–2014. MMWR Morb Mortal Wkly Rep. 2014;63(22):500–1.

Barzon L, Gobbi F, Capelli G, Montarsi F, Martini S, Riccetti S, et al. Autochthonous dengue outbreak in Italy 2020: clinical, virological and entomological findings. J Travel Med. 2021;28(8).

•• Bellone R, Lechat P, Mousson L, Gilbart V, Piorkowski G, Bohers C, et al. Climate change and vector-borne diseases: a multi-omics approach of temperature-induced changes in the mosquito. J Travel Med. 2023. In-depth data on how global warming may impact vectorial capacity and enable the mosquitoes to survive in temperate climates.

Wilder-Smith A, Lindsay SW, Scott TW, Ooi EE, Gubler DJ, Das P. The Lancet Commission on dengue and other Aedes-transmitted viral diseases. Lancet. 2020;395(10241):1890–1.

Article  PubMed  Google Scholar 

Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am. 2008;92(6):1377–90, x.

Nunes MR, Palacios G, Faria NR, Sousa EC Jr, Pantoja JA, Rodrigues SG, et al. Air travel is associated with intracontinental spread of dengue virus serotypes 1–3 in Brazil. PLoS Negl Trop Dis. 2014;8(4):e2769.

Article  PubMed  PubMed Central  Google Scholar 

Nasserie T, Brent SE, Tuite AR, Moineddin R, Yong JHE, Miniota J, et al. Association between air travel and importation of chikungunya into the USA. J Travel Med. 2019;26(5).

Hamer DH, Chen LH. Chikungunya: establishing a new home in the Western hemisphere. Ann Intern Med. 2014;161(11):827–8.

Article  PubMed  Google Scholar 

Rezza G. Chikungunya is back in Italy: 2007–2017. J Travel Med. 2018;25(1).

Wilder-Smith A. The expanding geographic range of dengue in Australia. Med J Aust. 2021;215(4):171–2.

Article  PubMed  Google Scholar 

• Osman S, Preet R. Dengue, chikungunya and Zika in GeoSentinel surveillance of international travellers: a literature review from 1995 to 2020. J Travel Med. 2020;27(8). Sets dengue in comparison with other vector borne diseases in ill returning travelers.

European Centre for Disease Prevention and Control (ECDC). Autochthonous transmission of dengue virus in mainland EU/EEA-pSEADA.

Zeller H, Van Bortel W, Sudre B. Chikungunya: Its history in Africa and Asia and its spread to new regions in 2013–2014. J Infect Dis. 2016;214(suppl 5):S436–40.

Article  PubMed  Google Scholar 

Pan American Health Organization 2023, With rising cases edCsitAhwpoen---r-c-e-d-c.

Vairo F, Haider N, Kock R, Ntoumi F, Ippolito G, Zumla A. Chikungunya: epidemiology, pathogenesis, clinical features, management, and prevention. Infect Dis Clin North Am. 2019;33(4):1003–25.

Article  PubMed  Google Scholar 

Langsjoen RM, Haller SL, Roy CJ, Vinet-Oliphant H, Bergren NA, Erasmus JH, et al. Chikungunya virus strains show lineage-specific variations in virulence and cross-protective ability in murine and nonhuman primate models. mBio. 2018;9(2).

Casais PM, Akrami K, Cerqueira-Silva T, Moraes LP, Rigaud VN, Neto ES, et al. Oral lesions are frequent in patients with chikungunya infection. J Travel Med. 2020;27(4).

Lang PO, Loulergue P, Aspinall R. Chikungunya Virus infection: why should U.S. geriatricians be aware of it? J Am Geriatr Soc. 2017;65(11):2529–34.

Perti T, Lucero-Obusan CA, Schirmer PL, Winters MA, Holodniy M. Chikungunya fever cases identified in the Veterans Health Administration System, 2014. PLoS Negl Trop Dis. 2016;10(5):e0004630.

Article  PubMed  PubMed Central  Google Scholar 

de Almeida Barreto FK, Montenegro RM, Fernandes VO, Oliveira R, de Araújo Batista LA, Hussain A, et al. Chikungunya and diabetes, what do we know? Diabetol Metab Syndr. 2018;10(1):32.

Article  PubMed  PubMed Central  Google Scholar 

Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L. Chikungunya virus infection: an overview. New Microbiol. 2013;36(3):211–27.

PubMed  Google Scholar 

Gérardin P, Barau G, Michault A, Bintner M, Randrianaivo H, Choker G, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med. 2008;5(3):e60.

Article  PubMed  PubMed Central  Google Scholar 

Calderwood C, Bhagani S, Cropley I, Papineni P. Severe chikungunya requiring intensive care in two travellers returning to the UK. J Travel Med. 2019;26(5).

Ahamed SF, Rosario V, Britto C, Dias M, Nayak K, Chandele A, et al. Emergence of new genotypes and lineages of dengue viruses during the 2012–15 epidemics in southern India. Int J Infect Dis. 2019;84S:S34–43.

Article  PubMed  Google Scholar 

Ernst T, McCarthy S, Chidlow G, Luang-Suarkia D, Holmes EC, Smith DW, et al. Emergence of a new lineage of dengue virus type 2 identified in travelers entering Western Australia from Indonesia, 2010–2012. PLoS Negl Trop Dis. 2015;9(1): e0003442.

Article  PubMed  PubMed Central  Google Scholar 

Andrade EH, Figueiredo LB, Vilela AP, Rosa JC, Oliveira JG, Zibaoui HM, et al. Spatial-temporal co-circulation of dengue virus 1, 2, 3, and 4 associated with coinfection cases in a hyperendemic area of Brazil: a 4-week survey. Am J Trop Med Hyg. 2016;94(5):1080–4.

Article  PubMed  PubMed Central  Google Scholar 

Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016.

L’Azou M, Moureau A, Sarti E, Nealon J, Zambrano B, Wartel TA, et al. Symptomatic dengue in children in 10 Asian and Latin American countries. N Engl J Med. 2016;374(12):1155–66.

Article  CAS  PubMed  Google Scholar 

Wilder-Smith A. Dengue during the COVID-19 pandemic. J Travel Med. 2021;28(8).

Lim JT, Dickens BL, Ong J, Aik J, Lee VJ, Cook AR, et al. Decreased dengue transmission in migrant worker populations in Singapore attributable to SARS-CoV-2 quarantine measures. J Travel Med. 2021;28(2).

Wilder-Smith A, Ooi EE, Horstick O, Wills B. Dengue Lancet. 2019;393(10169):350–63.

Article  PubMed  Google Scholar 

Sangkaew S, Ming D, Boonyasiri A, Honeyford K, Kalayanarooj S, Yacoub S, et al. Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis. Lancet Infect Dis. 2021;21(7):1014–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vouga M, Chiu YC, Pomar L, de Meyer SV, Masmejan S, Genton B, et al. Dengue, Zika and chikungunya during pregnancy: pre- and post-travel advice and clinical management. J Travel Med. 2019;26(8).

Paixão ES, Costa M, Teixeira MG, Harron K, de Almeida MF, Barreto ML, et al. Symptomatic dengue infection during pregnancy and the risk of stillbirth in Brazil, 2006–12: a matched case-control study. Lancet Infect Dis. 2017;17(9):957–64.

Article  PubMed  PubMed Central  Google Scholar 

•• Simon F, Caumes E, Jelinek T, Lopez-Velez R, Steffen R, Chen LH. Chikungunya: risks for travellers. J Travel Med. 2023;30(2). Most comprehensive analysis of chikungungya risk in travellers.

• Halstead S, Wilder-Smith A. Severe dengue in travellers: pathogenesis, risk and clinical management. J Travel Med. 2019;26(7). Comprehensive synthesis on the risk of dengue in travelers.

Hamer DH, Rizwan A, Freedman DO, Kozarsky P, Libman M. GeoSentinel: past, present and future dagger. J Travel Med. 2020;27(8).

Angelo KM. Twenty-five years: GeoSentinel's impact on travel-related surveillance and its vision for the future. J Travel Med. 2020;27(7).

Wilder-Smith A, Boggild AK. Sentinel surveillance in travel medicine: 20 years of GeoSentinel publications (1999–2018). J Travel Med. 2018;25(1).

Norman FF, Henríquez-Camacho C, Díaz-Menendez M, Chamorro S, Pou D, Molina I, et al. Imported arbovirus infections in Spain, 2009–2018. Emerg Infect Dis. 2020;26(4):658–66.

Article  PubMed  PubMed Central  Google Scholar 

Aoki Y, Terakawa I. Disease profiles created by the experience of imported febrile cases in resource-limited settings. J Travel Med. 2021;28(5).

Cobuccio LG, Laurent M, Gardiol C, Wampfler R, Poppert S, Senn N, et al. Should we treat Blastocystis sp.? A double-blind placebo-controlled randomized pilot trial. J Travel Med. 2023;30(1).

Camprubi-Ferrer D, Cobuccio L, Van Den Broucke S, Genton B, Bottieau E, d'Acremont V, et al. Causes of fever in returning travelers: a European multicenter prospective cohort study. J Travel Med. 2022;29(2).

Leder K, Tong S, Weld L, Kain KC, Wilder-Smith A, von Sonnenburg F, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network. Clin Infect Dis. 2006;43(9):1185–93.

Article  PubMed  Google Scholar 

Huits R, Schwartz E. Fatal outcomes of imported dengue fever in adult travelers from non-endemic areas are associated with primary infections. J Travel Med. 2021;28(5).

Ujiie M. Deaths due to dengue in Japanese travellers. J Travel Med. 2021;28(5).

World Health Organization. Geneva, Switzerland. 2022. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health#:~:text=By%202030%2C%201%20in%206,will%20double%20(2.1%20billion) accessed online on June 26th 2023.

Chong B, Kong G, Shankar K, Chew HSJ, Lin C, Goh R, et al. The global syndemic of metabolic diseases in the young adult population: a consortium of trends and projections from the Global Burden of Disease 2000–2019. Metabolism. 2023;141: 155402.

Article  CAS  PubMed  Google Scholar 

Greenaway C, Castelli F. Infectious diseases at different stages of migration: an expert review. J Travel Med. 2019;26(2).

Agyemang C, van den Born B-J. Cardiovascular health and disease in migrant populations: a call to action. Nat Rev Cardiol. 2022;19(1):1–2.

Article  PubMed  Google Scholar 

Hawman DW, Stoermer KA, Montgomery SA, Pal P, Oko L, Diamond MS, et al. Chronic joint disease caused by persistent chikungunya virus infection is controlled by the adaptive immune response. J Virol. 2013;87(24):13878–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Yoon IK, Srikiatkhachorn A, Alera MT, Fernandez S, Cummings DAT, Salje H. Pre-existing chikungunya virus neutralizing antibodies correlate with risk of symptomatic infection and subclinical seroconversion in a Philippine cohort. Int J Infect Dis. 2020;95:167–73. New insights on risk of symptomatic infection.

Article  CAS  PubMed  Google Scholar 

Folegatti PM, Harrison K, Preciado-Llanes L, Lopez FR, Bittaye M, Kim YC, et al. A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial. Nat Commun. 2021;12(1):4636.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Shaw CA, August A, Bart S, Booth PJ, Knightly C, Brasel T, et al. A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults. Vaccine. 2023. Pivotal trial.

https://www.clinicaltrials.gov/. Clinical trials.gov https://www.clinicaltrials.gov/

•• Reisinger EC, Tschismarov R, Beubler E, Wiedermann U, Firbas C, Loebermann M, et al. Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial. Lancet. 2019;392(10165):2718–27. Pivotal trial.

Article  PubMed  Google Scholar 

Goo L, Dowd KA, Lin TY, Mascola JR, Graham BS, Ledgerwood JE, et al. A virus-like particle vaccine elicits broad neutralizing antibody responses in humans to all chikungunya virus genotypes. J Infect Dis. 2016;214(10):1487–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Chen GL, Coates EE, Plummer SH, Carter CA, Berkowitz N, Conan-Cibotti M, et al. Effect of a chikungunya virus-like particle vaccine on safety and tolerability outcomes: a randomized clinical trial. JAMA. 2020;323(14):1369–77. Pivotal trial.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Bennett SR, McCarty JM, Ramanathan R, Mendy J, Richardson JS, Smith J, et al. Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial. Lancet Infect Dis. 2022;22(9):1343–55. Pivotal trial.

Article  CAS  PubMed  Google Scholar 

•• Akahata W, Yang ZY, Andersen H, Sun S, Holdaway HA, Kong WP, et al. A virus-like particle vaccine for epidemic chikungunya virus protects nonhuman primates against infection. Nat Med. 2010;16(3):334–8. Pivota